MedPath

Gastroesophageal Reflux Disease Prospective Registry

Terminated
Conditions
GERD
Interventions
Other: Diagnosed with GERD
Registration Number
NCT02479438
Lead Sponsor
Baylor Research Institute
Brief Summary

The purpose of this registry is to evaluate information to determine which operations and treatments for gastroesophageal reflux disease or similar diseases of the stomach, esophagus or digestive tract are providing the most benefit including the long-term effects of treatment (or no treatment) and the progression of the disease over time.

Detailed Description

All patients in this registry will have a diagnosis of gastroesophageal reflux disease or a similar disease of the stomach, esophagus or digestive tract. Each patient undergoing anti-reflux surgery will be asked to participate in the registry to gather preoperative, intraoperative and postoperative outcomes. The data collected from the registry will be used to assess the outcome of various treatments, both standard and new: some specific areas of interest include the long-term effects of treatment (or no treatment), the progression of the disease over time, and the overall length of survival of the patient.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
744
Inclusion Criteria
  • Any patient undergoing anti-reflux surgery
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Diagnosed with GERDDiagnosed with GERDCollect data on GERD patients
Primary Outcome Measures
NameTimeMethod
Postoperative patient reported sign and symptomsUp to 10 years after surgery

Patient reported signs and symptoms as reported in Reflux scale and GERD questionnaire.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Baylor Research University Medical Center

🇺🇸

Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath